data from its phase three clinical trial with MDMA-assisted therapy for post-traumatic stress disorder, showing that 67% of participants who received three treatments no longer qualified for a PTSD diagnosis and 88% experienced a clinically meaningful reduction in symptoms. Other companies like MindMed, which is studying LSD for anxiety and a modified version of ibogaine to treat opioid-use disorder, have also listed on Nasdaq.
Cybin’s phase two study will be conducted in two parts at Jamaica’s University of West Indies Hospital. The first part of the clinical trial will consist of a Phase IIa study of 40 patients to identify the equivalent dose of Cybin’s sublingual psilocybin formulation compared with a 25 mg pill of psilocybin. Cybin’s sublingual film is designed for rapid absorption, a faster onset, and a shorter duration.
Cybin is starting with psilocybin, but the company is developing novel molecules based on other psychedelic compounds. The company has filed 12 provisional patent applications for novel psychedelic compounds.
👀
For all those who are new to this working from home Bitcoin trading options Here's a little tip: Get a trusted Bitcoin expert and stick to him Blakescott64 Invest and play at similar times each day. Because : In times of chaos, your investment is your anchor to success
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: Forbes - 🏆 394. / 53 Read more »
Source: TheCut - 🏆 720. / 51 Read more »
Source: Forbes - 🏆 394. / 53 Read more »
Activists fight Compass Pathways over psychedelics patentsA fight over patents in the psychedelics industry is just getting started, and it stands to shape the future of a $100 billion market I've been saying for years that everyone should do LSD or shrooms at least once in their life, if not twice. The world would be much more compassionate, and the universe more connected. thanks Fuck it! .. Patents cannot - and should not - be allowed on natural organic products! They belong to all!!
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: Newsweek - 🏆 468. / 52 Read more »
Source: CNBC - 🏆 12. / 72 Read more »